Literature DB >> 25142963

Simultaneous dissection and comparison of IL-2 and IL-15 signaling pathways by global quantitative phosphoproteomics.

Nerea Osinalde1, Virginia Sanchez-Quiles, Vyacheslav Akimov, Barbara Guerra, Blagoy Blagoev, Irina Kratchmarova.   

Abstract

Common γ-chain family of cytokines (IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21, where IL stands for interleukin) are key regulators of the immune homeostasis that exhibit pleiotropic biological activities and even sometimes redundant roles as a result of the utilization of the same receptor subunit. However, they also exert distinct functions that make each of them to be indispensable. For instance, all family members can act as T-cell growth factors; however, we found that IL-15 but not IL-7 can replace IL-2 to promote and sustain the proliferation of Kit225T cells. In addition to the γ-chain, IL-2 and IL-15 share the β-chain, which creates the paradox of how they can trigger diverse phenotypes despite signaling through the same receptors. To investigate this paradigm, we combined SILAC with enrichment of tyrosine-phosphorylated proteins and peptides followed by mass spectrometric analysis to quantitatively assess the signaling networks triggered downstream IL-2/IL-2R and IL-15/IL-15R. This study confirmed that the transduction pathways initiated by both cytokines are highly similar and revealed that the main signaling branches, JAK/STAT, RAS/MAPK and PI3K/AKT, were nearly equivalently activated in response to both ILs. Despite that, our study revealed that receptor internalization rates differ in IL-2- and IL-15-treated cells indicating a discrete modulation of cytokine signaling. All MS data have been deposited in the ProteomeXchange with identifier PXD001129 (http://proteomecentral.proteomexchange.org/dataset/PXD001129).
© 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Cell biology; IL-15; IL-2; Quantitative phosphoproteomics; SILAC; Signaling

Mesh:

Substances:

Year:  2014        PMID: 25142963     DOI: 10.1002/pmic.201400194

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  11 in total

1.  Interleukin-2 Receptor β Thr-450 Phosphorylation Is a Positive Regulator for Receptor Complex Stability and Activation of Signaling Molecules.

Authors:  Blanca E Ruiz-Medina; Jeremy A Ross; Robert A Kirken
Journal:  J Biol Chem       Date:  2015-07-07       Impact factor: 5.157

2.  Nuclear Phosphoproteomic Screen Uncovers ACLY as Mediator of IL-2-induced Proliferation of CD4+ T lymphocytes.

Authors:  Nerea Osinalde; Jone Mitxelena; Virginia Sánchez-Quiles; Vyacheslav Akimov; Kerman Aloria; Jesus M Arizmendi; Ana M Zubiaga; Blagoy Blagoev; Irina Kratchmarova
Journal:  Mol Cell Proteomics       Date:  2016-04-11       Impact factor: 5.911

3.  SILAC-based quantification of changes in protein tyrosine phosphorylation induced by Interleukin-2 (IL-2) and IL-15 in T-lymphocytes.

Authors:  Nerea Osinalde; Virginia Sánchez-Quiles; Vyacheslav Akimov; Blagoy Blagoev; Irina Kratchmarova
Journal:  Data Brief       Date:  2015-08-22

4.  Integrative Phosphoproteomics Links IL-23R Signaling with Metabolic Adaptation in Lymphocytes.

Authors:  Corinne Lochmatter; Roman Fischer; Philip D Charles; Zhanru Yu; Fiona Powrie; Benedikt M Kessler
Journal:  Sci Rep       Date:  2016-04-15       Impact factor: 4.379

Review 5.  Lighting Up T Lymphocyte Signaling with Quantitative Phosphoproteomics.

Authors:  Candelas Álvarez-Salamero; Raquel Castillo-González; María N Navarro
Journal:  Front Immunol       Date:  2017-08-09       Impact factor: 7.561

6.  Low dose of IL-2 combined with rapamycin restores and maintains the long-term balance of Th17/Treg cells in refractory SLE patients.

Authors:  Chunmiao Zhao; Yanfang Chu; Zhaoyun Liang; Bingying Zhang; Xuxia Wang; Xiaona Jing; Meihua Hao; Yiqi Wang; Jia An; Xingzhe Zhang; Liguang Sun; Junwei Chen
Journal:  BMC Immunol       Date:  2019-09-04       Impact factor: 3.615

Review 7.  Engineered Cytokine Signaling to Improve CAR T Cell Effector Function.

Authors:  Matthew Bell; Stephen Gottschalk
Journal:  Front Immunol       Date:  2021-06-04       Impact factor: 7.561

8.  Changes in Gab2 phosphorylation and interaction partners in response to interleukin (IL)-2 stimulation in T-lymphocytes.

Authors:  Nerea Osinalde; Virginia Sánchez-Quiles; Blagoy Blagoev; Irina Kratchmarova
Journal:  Sci Rep       Date:  2016-03-30       Impact factor: 4.379

9.  Phosphoproteomic Analyses of Interleukin 2 Signaling Reveal Integrated JAK Kinase-Dependent and -Independent Networks in CD8(+) T Cells.

Authors:  Sarah H Ross; Christina Rollings; Karen E Anderson; Phillip T Hawkins; Len R Stephens; Doreen A Cantrell
Journal:  Immunity       Date:  2016-08-23       Impact factor: 31.745

10.  Mutant JAK3 phosphoproteomic profiling predicts synergism between JAK3 inhibitors and MEK/BCL2 inhibitors for the treatment of T-cell acute lymphoblastic leukemia.

Authors:  S Degryse; C E de Bock; S Demeyer; I Govaerts; S Bornschein; D Verbeke; K Jacobs; S Binos; D A Skerrett-Byrne; H C Murray; N M Verrills; P Van Vlierberghe; J Cools; M D Dun
Journal:  Leukemia       Date:  2017-08-30       Impact factor: 11.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.